Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL943564 | 0.79 | ALDH1A1 (0.31) | — | |
| SCHEMBL18736143 | 0.79 | TSHR (0.32) | — | |
| SCHEMBL20828067 | 0.79 | EPHX2 (0.31) | — | |
| SCHEMBL14343031 | 0.78 | — | — | |
| SCHEMBL20050041 | 0.76 | CA12 (0.31) | CA14 | |
| SCHEMBL25244137 | 0.75 | — | — | |
| SCHEMBL29867869 | 0.75 | TLR2 (0.31) | — | |
| SCHEMBL18349779 | 0.75 | RECQL (0.39) | CA14 | |
| SCHEMBL18705408 | 0.75 | TSHR (0.38) | — | |
| SCHEMBL14900159 | 0.75 | STING1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140023592-A1 | SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS | RWTH AACHEN (DE) | 2014-01-23 | — | — | US | disclosed |
| EP-2587263-A1 | Self coupling recombinant antibody fusion proteins | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2013-05-01 | — | — | EP | disclosed |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20100183516-A1 | SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2010-07-22 | — | — | US | disclosed |
| EP-2171456-A2 | SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009043899-A1 | DRUG TRANSFER INTO LIVING CELLS | COVALYS BIOSCIENCES AG (CH) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009043899-A1 | DRUG TRANSFER INTO LIVING CELLS | COVALYS BIOSCIENCES AG (CH) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009043900-A1 | DRUG TRANSFER BASED ON COENZYME A AND ACYL CARRIER PROTEIN | COVALYS BIOSCIENCES AG (CH) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009013359-A2 | SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS | FRAUNHOFER GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V. (DE) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014196-A1 | Drug Transfer into Living Cells | TSPO, MPI, ABCB1 | CA14 3061/4885MLYCD 372/4885 |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COASY, ACAT2, ACAT1 | CA14 3693/4885MLYCD 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.